With the analysis among 4,128 patents, we discovered top 448 key players by total patent application. Regeneron Pharmaceuticals, Inc., Genentech, Inc., Novartis AG are dominant in this area. They take 6.27% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 112
California, United States
Patent: 74
Basel-Stadt, Switzerland
Patent: 73
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 64
Antwerpen, Belgium
Patent: 57
New York, United States
Patent: 52
F. Hoffmann-La Roche Ltd.
Delaware, United States
Patent: 32
Madrigal Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 28
With the analysis among 401 patents, we discovered top 76 start-ups by total patent application. DRAGONFLY Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, Aleta Biotherapeutics, Inc. are active in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 64
Institut National de la Santé et de la Recherche Médicale
Aleta Biotherapeutics, Inc.
Massachusetts, United States
Patent: 28
Massachusetts, United States
Patent: 28
Obsidian Therapeutics, Inc.
Massachusetts, United States
Patent: 25
Oisin Biotechnologies, Inc.
Washington, United States
Patent: 16
Massachusetts, United States
Patent: 9
California, United States
Patent: 8
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 8
With the analysis among related 2,541 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., DRAGONFLY Therapeutics, Inc., Janssen Pharmaceutica NV take 7.16% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 78
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 64
Antwerpen, Belgium
Patent: 40
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 28
Massachusetts, United States
Patent: 28
Regents of the University of California
California, United States
Patent: 27
Obsidian Therapeutics, Inc.
Massachusetts, United States
Patent: 24
Aleta Biotherapeutics, Inc.
Massachusetts, United States
Patent: 24
Institut National de la Santé et de la Recherche Médicale
Delaware, United States
Patent: 21
With the analysis among related 2,541 patents in last 5 years, we discover 307 new entrants. DRAGONFLY Therapeutics, Inc., KSQ Therapeutics, Inc., Decibel Therapeutics, Inc. are the most active new entrants in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 64
Massachusetts, United States
Patent: 28
Decibel Therapeutics, Inc.
Massachusetts, United States
Patent: 19
Kezar Life Sciences, Inc.
California, United States
Patent: 17
Alpine Immune Sciences, Inc.
Washington, United States
Patent: 16
Massachusetts, United States
Patent: 13
Fulcrum Therapeutics, Inc.
Massachusetts, United States
Patent: 13
California, United States
Patent: 13
With the analysis among 1,320 patents, we discovered top 250 universities and scientific research institutions by total patent application. Massachusetts Institute of Technology, President & Fellows of Harvard College, The Scripps Research Institute are dominant in this area. They take 10.15% of the total patent filing.
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 28
President & Fellows of Harvard College
Massachusetts, United States
Patent: 23
The Scripps Research Institute
California, United States
Patent: 21
Consejo Superior de Investigaciones Científicas
Tennessee, United States
Patent: 15
Ontario, Canada
Patent: 15
National University of Singapore
Central Region, Singapore
Patent: 14
Hovedstaden, Denmark
Patent: 14
Vlaams Instituut voor Biotechnologie - Flanders Institute
The Johns Hopkins University